2017-08-30T13:57:52-05:00 2016-12-31 232896692 BBD LLP 1835 MARKET STREET 26TH FLOOR PHILADELPHIA PA 19103 990 2016-01-01 236251648 AMERICAN ASSOCIATION FOR CANCER RESEARCH INC AMER 2154409300 615 CHESTNUT STREET 17TH FLOOR PHILADELPHIA PA 19106 MICHAEL STEWART CHIEF FINANCIAL OFFICER 2154409300 2017-08-30 1 JENNIFER SOLOT P00749373 2155677770 38.88.148.130 2017-08-30 14:57:44 ED P 11AE3E88E8C2217D7D81F7CFE1570750383F7E13 11AE3E88E8C2217D7D81F7CFE1570750383F7E13 2016 2021-01-29 14:40:06Z MICHAEL STEWART 615 CHESTNUT STREET 17TH FLOOR PHILADELPHIA PA 19106 92247373 0 X WWW.AACR.ORG X 1907 NY PREVENT AND CURE CANCER THROUGH RESEARCH, EDUCATION, COMMUNICATION AND COLLABORATION. 24 24 204 5000 382461 118434 36833629 44734050 39788570 41724859 2051428 631508 580813 574554 79254440 87664971 29199098 35820509 0 0 18513141 19441479 0 0 1548516 28666970 29305882 76379209 84567870 2875231 3097101 109009290 117885019 42468333 44387990 66540957 73497029 X THE MISSION OF THE AACR IS TO PREVENT AND CURE CANCER THROUGH RESEARCH,EDUCATION, COMMUNICATION, AND COLLABORATION. THROUGH ITS PROGRAMS AND SERVICES, THE AACR FOSTERS RESEARCH IN CANCER AND RELATED BIOMEDICAL SCIENCE; ACCELERATES THE (SEE SCHEDULE O FOR CONTINUATION) DISSEMINATION OF NEW RESEARCH FINDINGS AMONG SCIENTISTS AND OTHERS DEDICATED TO THE CONQUEST OF CANCER; PROMOTES SCIENCE EDUCATION AND TRAINING; AND ADVANCES THE UNDERSTANDING OF CANCER ETIOLOGY, PREVENTION, DIAGNOSIS AND TREATMENT THROUGHOUT THE WORLD. 0 0 38460729 35314144 RESEARCH GRANTS, SCIENTIFIC AWARDS, FELLOWSHIPS AND CAREER DEVELOPMENT AWARDS. 15633634 326415 18988094 ANNUAL MEETING AND SPECIAL CONFERENCES ATTENDED BY MEMBERS AND NON-MEMBERS FOR THE PRESENTATION OF SCIENTIFIC RESEARCH. ALSO INCLUDES EDUCATIONAL WORKSHOPS FOR TRAINING YOUNG INVESTIGATORS. 12777847 17782166 PUBLICATIONS - PRODUCTION & DISTRIBUTION OF THE JOURNALS: "CANCER RESEARCH", "MOLECULAR CANCER RESEARCH", "CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION", "CLINICAL CANCER RESEARCH", "MOLECULAR CANCER THERAPEUTICS", "CANCER PREVENTION RESEARCH", "CANCER DISCOVERY", "CANCER TODAY AND "CANCER IMMUNOLOGY RESEARCH". 2655751 [1] SCIENCE POLICY AND GOVERNMENT AFFAIRS 3631629 [2] COMMUNICATIONS 1520373 179950 926400 [3] SPECIAL CONSTITUENCIES - CONSISTS OF SERVICES TO UNDER-REPRESENTED POPULATIONS (WOMEN, MINORITIES, UNDERGRADUATES) TO ENHANCE THEIR SCIENTIFIC CAREERS. 2472979 [4] SCIENTIFIC PROJECTS AND PROGRAMS 248327 [5] SURVIVOR PROGRAM 4028199 [6] MEMBERSHIP 10529059 179950 4954599 77401269 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 0 1 0 0 1 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 396 0 204 1 1 1 1 CA 0 0 0 0 0 0 0 0 X 24 24 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT DC FL GA HI IL KS KY LA ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X MICHAEL STEWART CHIEF FINANCIAL OFFICER 2154409300 615 CHESTNUT ST 17TH FLOOR PHILADELPHIA PA 19106 X DR NANCY DAVIDSON PRESIDENT (APR-DEC) 5.00 1.00 X X 0 0 0 DR NANCY DAVIDSON PRESIDENT-ELECT (JAN-MAR) 5.00 X X 0 0 0 DR MICHAEL A CALIGIURI PRESIDENT-ELECT (APR-DEC) 5.00 X X 0 0 0 DR CARLOS L ARTEAGA PAST PRESIDENT (JAN-MAR) 5.00 1.00 X X 0 0 0 DR JOSE BASELGA PAST PRESIDENT (APR-DEC) 5.00 1.00 X X 0 0 0 DR JOSE BASELGA PRESIDENT (JAN-MAR) 5.00 X X 0 0 0 DR WILLIAM N HAIT TREASURER 5.00 1.00 X X 0 0 0 DR MARY C BECKERLE DIRECTOR (2013-2016) 2.00 X 0 0 0 DR MICHAEL A CALIGIURI DIRECTOR (2013-2016) 2.00 X 0 0 0 DR HANS CLEVERS DIRECTOR (2013-2016) 2.00 X 0 0 0 DR ELIZABETH M JAFFEE DIRECTOR (2013-2016) 2.00 X 0 0 0 DR VICTOR E VELCULESCU DIRECTOR (2013-2016) 2.00 X 0 0 0 DR JAMES P ALLISON DIRECTOR (2014-2017) 2.00 X 0 0 0 DR RONALD M EVANS DIRECTOR (2014-2017) 2.00 X 0 0 0 DR SCOTT M LIPPMAN DIRECTOR (2014-2017) 2.00 X 0 0 0 DR GUILLERMINA LOZANO DIRECTOR (2014-2017) 2.00 X 0 0 0 DR M CELESTE SIMON DIRECTOR (2014-2017) 2.00 X 0 0 0 DR GEORGE DEMITRI DIRECTOR (2015-2018) 2.00 X 0 0 0 DR RICHARD MARAIS DIRECTOR (2015-2018) 2.00 X 0 0 0 DR ELAINE MARDIS DIRECTOR (2015-2018) 2.00 X 0 0 0 DR EDITH PEREZ DIRECTOR (2015-2018) 2.00 X 0 0 0 DR PATRICIA LORUSSO DIRECTOR (2015-2018) 2.00 X 0 0 0 DR ALAN ASHWORTH DIRECTOR (2016-2019) 2.00 X 0 0 0 DR DAFNA BAR-SAGI DIRECTOR (2016-2019) 2.00 X 0 0 0 DR KAREN CICHOWSKI DIRECTOR (2016-2019) 2.00 X 0 0 0 DR LEVI GARRAWAY DIRECTOR (2016-2019) 2.00 X 0 0 0 DR ANTONI RIBAS DIRECTOR (2016-2019) 2.00 X 0 0 0 DR MARGARET FOTI CHIEF EXECUTIVE OFFICER 35.00 5.00 X 725388 79532 40758 MICHAEL STEWART CHIEF FINANCIAL OFFICER 35.00 5.00 X 290700 15300 47517 JON RETZLAFF MG. DIRECTOR / SCIENCE POLICY 40.00 X 294525 0 37357 CHRISTINE B RULLO PUBLISHER 40.00 X 232560 0 33266 JOSEPH PONTOSKI SR. DIRECTOR / FINANCE 40.00 X 200732 0 38292 RICHARD G BUCK SR. DIRECTOR / COMMUNICATIONS 40.00 X 207851 0 30243 PAUL DRISCOLL SR. DIRECTOR / GRAPHICS & CREATIVE SERVICE 40.00 X 168300 0 36213 2120056 94832 263646 42 0 1 0 THE SHERIDAN PRESS PO BOX 414784 BOSTON MA 02241 JOURNAL PRINTING AND MANUFACTURING 1206817 AV CONCEPTS 1917 W 1ST STREET TEMPE AZ 85281 AUDIO VISUAL SERVICES 1039579 REACTION AUDIO VISUAL 9951 MUIRLANDS BLVD IRVINE CA 92618 AUDIO VISUAL SERVICES 888878 FREEMAN COMPANIES PO BOX 650036 DALLAS TX 75265 EXHIBIT SERVICES 832609 MARRIOTT BUSINESS SERVICES PO BOX 403003 ATLANTA GA 30384 CONFERENCE SERVICES 719761 58 43884791 849259 44734050 CONFERENCES/WORKSHOPS 541800 18988094 14968103 162633 3857358 PUBLICATIONS 541800 17782166 17562338 219828 MEMBERSHIP 541800 4028199 4028199 926400 926400 41724859 888301 888301 574554 574554 4325609 4582402 -256793 -256793 -256793 87664971 37485040 382461 5063420 34760663 34760663 1059846 1059846 1096952 793601 303351 14589056 12137082 2450749 1225 803491 676414 127077 1978970 1525601 453369 973010 818683 154327 148030 126838 19918 1274 142745 122308 19207 1230 2802148 2400986 377037 24125 3192708 3106880 85828 1396142 1134599 239539 22004 1087951 957048 130315 588 2374921 1945147 429774 2265087 2163590 84291 17206 9350294 9068282 282012 1460000 1460000 211759 133563 78196 144767 126444 18323 PRINTING AND PRODUCTION 4157472 3923935 230526 3011 MISCELLANEOUS 344865 192766 134246 17853 BAD DEBT EXPENSE 195732 195732 UNRELATED BUS. INC. TAX 31261 31261 84567870 77401269 5618085 1548516 1607033 1746396 11253479 17264800 19372959 17213422 1612633 1672851 1612444 2079873 6033254 5878886 291801 154368 66318957 69848604 6939984 7904705 109009290 117885019 5184281 6406322 17450252 16648167 13237971 13685457 6595829 7648044 42468333 44387990 X 56434883 62405709 10106074 11091320 66540957 73497029 109009290 117885019 X 3097101 2894250 964721 X 0 1 X 1 1 1 X 37372559 33896554 36010771 36833629 44734050 188847563 25621339 31438389 31654052 35771453 37485040 161970273 2750375 2812407 2863799 3459333 3857358 15743272 65744273 68147350 70528622 76064415 86076448 366561108 36480613 33049457 35190174 35961578 43884791 184566613 0 36480613 33049457 35190174 35961578 43884791 184566613 181994495 1804663 1146468 2150485 1991884 1462855 8556355 216105 248092 199554 172191 88995 924937 2020768 1394560 2350039 2164075 1551850 9481292 67765041 69541910 72878661 78228490 87628298 376042400 0.48400 0.49850 0.02520 0.02760 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 117473 176209 293682 82488869 82782551 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 241305 292420 297168 293682 1124575 250000 250000 250000 250000 1000000 1500000 96522 116968 118867 117473 449830 794480 778000 58723 36000 1595203 441913 363000 -10433 794480 435078 6835 441913 417980 17098 435078 407389 10591 417980 1.00000 0 1 1 588124 560678 27446 5445130 5318208 126922 154368 INTEREST IN NET ASSETS OF AFFILIATE 7904705 7904705 PAYABLE TO AFFILIATE 7648044 7648044 X 94227781 2894250 49013351 51907601 42320180 45344791 45344791 87664971 87218647 47995568 47995568 39223079 45344791 45344791 84567870 PART V, LINE 4: THE INCOME FROM THE FUNDS IS USED FOR EDUCATIONAL SESSIONS AT THE AACR ANNUAL MEETING AND OTHER PURPOSES. PART X, LINE 2: UNCERTAIN TAX POSITIONS UNDER ASC 740 GAAP PRESCRIBES A MINIMUM RECOGNITION THRESHOLD THAT A TAX POSITION IS REQUIRED TO MEET IN ORDER TO BE RECOGNIZED IN THE FINANCIAL STATEMENTS. AACR BELIEVES THAT THEY HAD NO UNCERTAIN TAX POSITIONS AS DEFINED IN GAAP. PART XI, LINE 2D - OTHER ADJUSTMENTS: REVENUE OF AFFILIATES 49,013,351. PART XI, LINE 4B - OTHER ADJUSTMENTS: INTERCOMPANY REVENUE 45,344,791. PART XII, LINE 2D - OTHER ADJUSTMENTS: EXPENSES OF AFFILIATES 47,995,568. PART XII, LINE 4B - OTHER ADJUSTMENTS: INTERCOMPANY EXPENSES 45,344,791. 1 CENTRAL AMERICA AND THE CARIBBEAN 0 0 OFFSHORE INVESTMENTS 13861196 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION GRANT MAKING 1059846 0 0 0 0 0 0 14921042 0 14921042 RESEARCH & SCIENTIFIC AWARDS EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIU 6 1059846 CHECK 0 0 0 0 0 0 PART I, LINE 2: ALL GRANTEES ARE REQUIRED TO PROVIDE YEARLY PROGRESS REPORTS. ALL BUDGET ITEMS MUST BE JUSTIFIED IN CONNECTION WITH THE PROGRAM GUIDELINES; ANY DISCREPANCY OR UNEXPECTED FUNDS MUST BE RETURNED TO THE GRANTOR. PART I, LINE 3: THE ORGANIZATION USES THE ACCRUAL METHOD TO ACCOUNT FOR EXPENDITURES. 1 RESEARCH GRANTS 23 27153298 CAREER DEVELOPMENT AWARDS 16 3876000 PRE & POST DOCTORAL FELLOWSHIPS 24 2990000 SCIENTIFIC AWARDS 16 235000 TRAVEL AWARDS 367 506365 PART I, LINE 2: ALL GRANTEES ARE REQUIRED TO PROVIDE YEARLY PROGRESS REPORTS. ALL BUDGET ITEMS MUST BE JUSTIFIED IN CONNECTION WITH THE PROGRAM GUIDELINES; ANY DISCREPANCY OR UNEXPECTED FUNDS MUST BE RETURNED TO THE GRANTOR. X 1 1 X X X X X 0 0 0 0 0 0 0 0 0 DR MARGARET FOTI CHIEF EXECUTIVE OFFICER 612391 68043 0 0 112997 11489 19080 2120 16642 2916 761110 84568 0 0 MICHAEL STEWART CHIEF FINANCIAL OFFICER 290700 15300 0 0 0 0 23256 1224 21885 1152 335841 17676 0 0 JON RETZLAFF MG. DIRECTOR / SCIENCE POLICY 294525 0 0 0 0 0 23562 0 13795 0 331882 0 0 0 CHRISTINE B RULLO PUBLISHER 232560 0 0 0 0 0 18605 0 14661 0 265826 0 0 0 JOSEPH PONTOSKI SR. DIRECTOR / FINANCE 200732 0 0 0 0 0 16059 0 22233 0 239024 0 0 0 RICHARD G BUCK SR. DIRECTOR / COMMUNICATIONS 207851 0 0 0 0 0 16628 0 13615 0 238094 0 0 0 PAUL DRISCOLL SR. DIRECTOR / GRAPHICS & CREATIVE S 168300 0 0 0 0 0 13464 0 22749 0 204513 0 0 0 PART I, LINE 1A SCHEDULE J, PART I, LINE 1A: FIRST-CLASS OR CHARTER TRAVEL IT IS THE POLICY OF THE ASSOCIATION TO AUTHORIZE FIRST CLASS TRAVEL ARRANGEMENTS FOR THE CHIEF EXECUTIVE OFFICER IN ORDER TO ACCOMMODATE BUSINESS TRAVEL SCHEDULES AND FACILITATE ONGOING BUSINESS TRANSACTIONS. SCHEDULE J, PART II: OTHER REPORTABLE COMPENSATION THE EMPLOYMENT CONTRACT FOR THE AACR CEO CALLS FOR ANNUAL CONTRIBUTIONS TO A DEFERRED COMPENSATION PLAN. DUE TO STATUTORY AND REGULATORY REQUIREMENTS, A PORTION OF THESE ANNUAL PAYMENTS CAN NO LONGER BE DEFERRED INTO A QUALIFIED PLAN AND MUST BE PAID OUT ANNUALLY AND CLASSIFIED AS OTHER REPORTABLE COMPENSATION. IN ADDITION, THE COMPANY PROVIDES AN ANNUAL CAR ALLOWANCE THAT IS ALSO INCLUDED AS PART OF OTHER COMPENSATION. FORM 990, PART VI, SECTION A, LINE 6 MEMBERS THE ORGANIZATION HAS ONE CLASS OF VOTING MEMBER. EACH VOTING MEMBER IS ELIGIBLE TO VOTE OR TO HOLD THE OFFICE AND HAS THE SAME VOTING RIGHT - ONE VOTE PER MEMBER. FORM 990, PART VI, SECTION A, LINE 7A ELECTION OF MEMBERS OF GOVERNING BODY ELECTION OF MEMBERS OF THE GOVERNING BODY SHALL BE BY BALLOT DISTRIBUTED TO VOTING MEMBERS OF THE ORGANIZATION. THE CANDIDATE RECEIVING THE HIGHEST NUMBER OF VOTES CAST SHALL BE ELECTED. FORM 990, PART VI, SECTION A, LINE 7B GOVERNING BODY DECISIONS SUBJECT TO APPROVAL BY MEMBERS DECISIONS OF THE BOARD TO AMEND THE BY-LAWS OR TO AUTHORIZE THE ESTABLISHMENT OF A LOCAL SECTION REQUIRE APPROVAL BY MEMBERSHIP OF THE ASSOCIATION. FORM 990, PART VI, SECTION B, LINE 11B GOVERNING BODY REVIEW OF FORM 990 PRIOR TO ITS FILING WITH THE IRS, A COPY OF THE FINAL FORM 990 IS PROVIDED TO EACH VOTING MEMBER OF THE GOVERNING BODY AND TO THE FINANCE AND AUDIT COMMITTEE ON AN ANNUAL BASIS AS PART OF THEIR FIDUCIARY RESPONSIBILITY TO UNDERSTAND AND REVIEW THE ORGANIZATION'S FINANCES. FORM 990, PART VI, SECTION B, LINE 12C MONITORING AND ENFORCEMENT OF CONFLICT OF INTEREST POLICY EACH VOTING MEMBER OF THE GOVERNING BODY IS REQUIRED TO ANNUALLY ACKNOWLEDGE ANY CONFLICTS BY SIGNING THE CORPORATE CONFLICT OF INTEREST STATEMENT AND DETAILING ALL POTENTIAL CONFLICTS. FORM 990, PART VI, SECTION B, LINE 15 PROCESS FOR DETERMINING COMPENSATION INDEPENDENT DATA DETAILING COMPARABLE COMPENSATION IS PURCHASED ANNUALLY AND PROVIDED TO A COMPENSATION COMMITTEE WHICH EVALUATES SALARY LEVELS IN COMPARISON TO PEER GROUPS. FORM 990, PART VI, SECTION C, LINE 19 PUBLIC AVAILABILITY OF OTHER DOCUMENTS THE FINANCIAL STATEMENTS AND FORM 990 ARE POSTED ON THE ORGANIZATION'S WEBSITE (WWW.AACR.ORG). THEY WILL BE PROVIDED ON REQUEST, AND ARE ALSO AVAILABLE FOR INSPECTION AT THE ORGANIZATION'S OFFICE. FORM 990, PART VII, SECTION A, COMPENSATION FROM RELATED ORGANIZATION FOR THE CEO AND CFO, THE ALLOCATION IS BASED UPON AN ESTIMATE OF THE AMOUNT OF THEIR TIME SPENT IN THIS AREA - 10% FOR THE CEO, 5% FOR THE CFO. FORM 990, PART XI, LINE 9: CHANGE IN INTEREST IN NET ASSETS OF AFFILIATE-UNRESTRICTED 133,998. CHANGE IN INTEREST IN NET ASSETS OF AFFILIATE-TEMP. RESTRICTED 30,000. CHANGE IN INTEREST IN NET ASSETS OF AFFILIATE-PERM. RESTRICTED 800,723. SCHEDULE R, PART II, COL B: PRIMARY ACTIVITY THE PURPOSE OF THE AACR FOUNDATION IS TO RAISE FUNDS AND SOLICIT GRANTS AND CONTRIBUTIONS TO BENEFIT, SUPPORT AND PROMOTE ITS PARENT ORGANIZATION - AACR'S MISSION IS DESCRIBED ON PAGE 2, PART III. THE PURPOSE OF AACR INTERNATIONAL - CANADA IS TO PROMOTE HEALTH BY SUPPORTING, MANAGING AND CONDUCTING NEW AND INNOVATIVE RESEARCH FOR THE CURE, PREVENTION AND TREATMENT OF CANCER, AND BY FOSTERING COLLABORATION AMONGST SCIENTISTS ENGAGED IN CANCER RESEARCH. IT INTENDS TO ADVANCE EDUCATION BY DEVELOPING AND OPERATING PROGRAMS, CONFERENCES, SEMINARS AND WORKSHOPS DESIGNED TO TRAIN STUDENTS AND SCIENTISTS AND ADVANCE THEIR UNDERSTANDING OF CANCER ETIOLOGY, PREVENTION, DIAGNOSIS AND TREATMENT. AMERICAN ASSOCIATION FOR CANCER RESEARCH FOUNDATION 615 CHESTNUT STREET 17TH FLOOR PHILADELPHIA PA 19106 233100004 SEE SCHEDULE O FOR DETAILS PA 501(C)(3) LINE 12A, I AMERICAN ASSOCIATION FOR CANCER RESEARCH INC 1 AMERICAN ASSOCIATION FOR CANCER RESEARCH INTERNATIONAL - CANADA C/O TMF CANADA MANAGEMENT INC SUI TORONTO ONTARIO CA SEE SCHEDULE O FOR DETAILS CA 501(C)(3) LINE 10 AMERICAN ASSOCIATION FOR CANCER RESEARCH INC 1 0 0 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 0 AMERICAN ASSOCIATION FOR CANCER RESEARCH FOUNDATION (SUPPORTING ORG) C 43884791 ACCRUAL METHOD AMERICAN ASSOCIATION FOR CANCER RESEARCH FOUNDATION (SUPPORTING ORG) R 1460000 ACCRUAL METHOD